大约一半的病例目前归为具有复发高风险,尽管采取彻底的多重模型疗法,存活率也不超过40%。
Around half of all cases are currently classified as high-risk for disease relapse, with overall survival rates less than 40% despite intensive multimodal therapy.
大约一半的病例目前归为具有复发高风险,尽管采取彻底的多重模型疗法,存活率也不超过40%。
Around half of all cases are currently classified as high-risk for disease relapse, with overall survival rates less than 40% despite intensive multimodal therapy.
应用推荐